Filed Pursuant to Rule 424(b)(3)
Registration No. 333-194825
PROSPECTUS
Forward Industries, Inc.
1,341,765 Shares of Common Stock
_______________
This prospectus covers the resale of up to 1,341,765 shares of common stock, $0.01 par value per share, of Forward Industries, Inc., a New York corporation, by the selling stockholders listed in this prospectus or their permitted transferees from time to time. The shares of common stock being offered by the selling stockholders consist of (i) 692,919 shares of common stock issuable to the selling stockholders upon conversion of outstanding shares of 6% Senior Convertible Preferred Stock, par value $0.01 per share (the “Convertible Preferred Stock”) and (ii) 648,846 shares of common stock issuable upon the exercise of outstanding warrants (the “Warrants,” and together with the Convertible Preferred Stock, the “Securities”). The Securities were originally issued to accredited investors in a series of private placements completed on June 28, 2013, August 7, 2013, and August 14, 2013. Please refer to the section of this prospectus entitled “Description of the Private Placements” for a description of the Securities and the section entitled “Selling Stockholders” for additional information.
We will not receive any proceeds from the sale of shares of our common stock by the selling stockholders. However, we will receive payment in cash upon any exercise of the warrants, and any proceeds we receive will be used for general corporate purposes, including working capital and in connection with potential acquisition targets that would be complementary to our existing business and allow us to further leverage our operating infrastructure, if any are identified and acquired. We will bear the costs and fees of the registration of the shares, and the selling stockholders will bear all commissions and discounts, if any, attributable to the sales of the shares.
Subject to the restrictions described in this prospectus, the selling stockholders (directly, or through agents or dealers designated from time to time) may sell the shares of our common stock being offering by this prospectus from time to time, on terms to be determined at the time of sale. The prices at which the selling stockholders may sell the shares will be determined by the prevailing market price for the shares or in negotiated transactions. Please see the section titled “Plan of Distribution” for more information regarding the offering of the shares.
Our common stock is listed on the NASDAQ Capital Market under the trading symbol “FORD.” On April 2, 2014, the last reported sale price for our common stock as reported on the NASDAQ Capital Market was $1.78 per share.
_______________
Investing in our common stock involves a high degree of risk. You should carefully read and evaluate the cautionary statements concerning risk factors included in our periodic reports and other information that we file with the Securities and Exchange Commission (the “SEC” or “Commission”). See “Risk Factors” beginning on page 4.
_______________
Neither the SEC nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of this prospectus. Any representation to the contrary is a criminal offense.
THIS PROSPECTUS IS NOT AN OFFER TO SELL SECURITIES, NOR IS IT A SOLICITATION OF AN OFFER TO BUY SECURITIES, IN ANY STATE OR COUNTRY WHERE THE OFFER OR SALE IS NOT PERMITTED.
_______________
The date of this prospectus is April 4, 2014
TABLE OF CONTENTS
|
Page
|
|
| 1 | |
| 4 | |
| 5 | |
| 5 | |
| 6 | |
| 6 | |
| 6 | |
| 8 | |
| 10 | |
| 13 | |
| 15 | |
| 18 | |
| 18 | |
| 18 | |
| 19 |
You should rely only on the information provided in this prospectus or in any free writing prospectus prepared by or on behalf of us or to which we have referred you. We have not authorized anyone to provide you with different information. The information contained in this prospectus is accurate only as of the date of this prospectus, regardless of the time of delivery of this prospectus or of any sale of our common stock. Our business, financial condition, results of operations and prospects may have changed since that date.
Persons outside the United States who come into possession of this prospectus must inform themselves about, and observe any restrictions relating to, the offering of the shares of common stock and the distribution of this prospectus outside of the United States.
We obtained statistical data, market data and other industry data and forecasts used throughout this prospectus from market research, publicly available information and industry publications. While we believe that the statistical data, industry data and forecasts and market research are reliable, we have not independently verified the data, and we do not make any representation as to the accuracy of the information.
i
Prospectus Summary
This summary highlights certain information contained elsewhere in this prospectus and does not contain all of the information that you should consider in making an investment decision. We urge you to read this entire prospectus carefully, including the “Risk Factors” section beginning on page 4 and the other information and documents incorporated by reference into this prospectus, including our consolidated financial statements and related notes, before making an investment decision.
Unless the context provides otherwise, all references in this prospectus to “Forward,” “we,” “us,” “our,” the “Company,” the “Registrant” or similar terms, refer to Forward Industries, Inc.
Forward Industries, Inc.
General
We design, market, and distribute carry and protective solutions, primarily for hand held electronic devices, including soft-sided carrying cases, bags, clips, hand straps, protective plates and other accessories made of leather, nylon, vinyl, plastic, PVC and other synthetic materials. Our principal customer market is original equipment manufacturers, or “OEMs” (or the contract manufacturing firms of these OEM customers), that either package our products as accessories “in box” together with their branded product offerings, or sell them through their retail distribution channels. Our OEM products include carrying cases and other accessories for blood glucose monitoring kits and a variety of other portable electronic and non-electronic products (such as sporting and recreational products, bar code scanners, smartphones, GPS and location devices, tablets, firearms and other products). Our carrying cases are designed to enable these devices to be stowed in a pocket, handbag, briefcase, or backpack, clipped to a belt or shoulder strap, or strapped to an arm, while protecting the consumer electronic or other product from scratches, dust, and mishandling. Our OEM customers are located in the Americas, Europe, and the Asia Pacific Region, or “APAC Region.” We do not manufacture any of our OEM products and source substantially all of our OEM products from independent suppliers in China.
On June 21, 2012, we determined to exit our global retail business and focus solely on growing our OEM business. Our decision to eliminate the global retail division was primarily driven by the longer than estimated path to bring it to profitability and the strong net sales growth and cost rationalizations in the OEM business. We have substantially completed the exit of our global retail business and have not had, and do not expect to have, any continuing involvement in the global retail business after this date.
Corporate History
Forward Industries was incorporated in 1961 under the laws of the State of New York as a manufacturer and distributer of advertising specialty and promotional products. In 1989, we acquired Forward US (then known as Koszegi Industries, Inc.), a manufacturer of soft-sided carrying cases. The carrying case business became our predominant business, and in September 1997, we sold the assets relating to the production of advertising specialty and promotional products, ceasing to operate in that segment.
In May 2001, we formed Forward Switzerland to facilitate distribution of aftermarket products under our licenses for cell phone cases with a major North American multinational and to further develop our OEM European business presence. After the expiration of the last of these licenses in March 2009, staff at Forward Switzerland was significantly reduced and in recent years has primarily served our OEM customers in Europe.
Products
Diabetic Products
We sell carrying cases for blood glucose diagnostic kits (“Diabetic Products”) directly to OEMs (or their contract manufacturers) of these electronic monitoring kits made for use by diabetics. We typically sell these cases at prices ranging from approximately $0.50 to $6.00 per unit. Unit volumes are sold predominantly at the lower end of this price range. The OEM customer (or its contract manufacturer) packages our carry cases “in box” as a custom accessory for the OEM’s blood glucose testing and monitoring kits, or to a much lesser extent, sells them through their retail distribution channels. These kits typically include a small, electronic blood glucose monitor, testing strips, lancets for drawing a drop of blood and our carrying case, customized with the manufacturer’s logo and designed to fit and secure the glucose monitor, testing strips, and lancets in separate straps, pouches, and holders. As the kits and technology change, our carrying case designs change to accommodate the changes in size, shape and layout of the electronic monitoring device, strips and lancet. For our fiscal year ended September 30, 2013 (“Fiscal 2013”), our Diabetic Products accounted for approximately 78% of our total net sales.
1
Other Products
We also sell carrying and protective solutions to OEMs for a diverse array of other portable electronic and other products (“Other Products”), including sporting and recreational products, bar code scanners, smartphones, GPS and location devices, tablets, and firearms, on a made-to-order basis that are customized to fit the products sold by our OEM customers. Our selling prices for these products also vary across a broad range, depending on the size and nature of the product for which we design and sell the carry solution. For Fiscal 2013, our Other Products accounted for approximately 22% of our total net sales.
Product Development
In our OEM business, the product life cycle in distributing and selling our technology solutions to our OEM customers is as described below. We typically receive requests to submit product designs in connection with a customer’s introduction and rollout to market of a new product that the customer has determined to accessorize and customize with a carry solution. Our OEM customers furnish the desired functionality, size and other basic specifications for the carrying solutions or other product, including the OEM’s identifying logo imprint on the product. Our design and production resources develop more detailed product specifications and design options for our customer’s evaluation. We then furnish the customer with product samples. Working with our suppliers and the customer, samples are modified and refined. Once approved for commercial introduction and order by our customer, we work with our suppliers to ensure conformity of commercial production to the definitive product samples and specifications. Manufacture and delivery of products in production quantities are coordinated with the customer’s manufacturing and shipment schedules so that our carry solution products are available with the customer’s product (and included “in box,” as the case may be) prior to shipment and sale, or to a lesser extent sold by our customer through its retail distribution channels.
Company Information
Our principal executive offices are located at 477 Rosemary Avenue, Suite 219, West Palm Beach, Florida 33401, and our telephone number is (561) 465-0030.
2
The Offering
On June 28, 2013, August 7, 2013 and August 14, 2013, the Company completed private placements (the “Private Placements”) of a total of 648,846 shares of Convertible Preferred Stock and Warrants to purchase 648,846 shares of common stock to accredited investors (the “Investors”).
The total purchase price paid by the Investors for each share of Convertible Preferred Stock and Warrant purchased was $1.965, consisting of (i) fair values ranging from $1.105 to $1.145 in respect of the Convertible Preferred Stock, plus (ii) fair values ranging from $0.82 to $0.86 in respect of the Warrants. The Warrants have an initial exercise price of $1.84 per share, subject to adjustment upon the occurrence of certain customary events. The Warrants are exercisable at any time on or after January 1, 2014 (the “Initial Exercise Date”) and terminate on the 10-year anniversary of the Initial Exercise Date. Each share of Convertible Preferred Stock is convertible into one share of our common stock at an initial conversion price of $1.84 per share, subject to adjustment upon the occurrence of certain customary events (the “Conversion Price”). At the initial Conversion Price, the total of 648,846 shares of Convertible Preferred Stock issued in the Private Placements are convertible into an aggregate of 692,919 shares of Common Stock.
We received gross proceeds of approximately $1,275,000 from the Private Placements, which we have used and will use for general corporate purposes, including working capital and in connection with potential acquisition targets that would be complementary to our existing business and allow us to further leverage our operating infrastructure, if any are identified and acquired. We filed the registration statement of which this prospectus is a part to fulfill certain of our contractual obligations under the registration rights agreements we entered into with the Investors.
As of March 17, 2014, there were 8,195,808 shares of our common stock outstanding (6,289,989 shares held by non-affiliates). Up to 1,341,765 shares are offered hereby. If all 1,341,765 shares offered by the selling stockholders hereby were issued and outstanding as of the date hereof, such shares would represent approximately 16.4% of our total common stock outstanding, or 21.3% of total common stock outstanding held by non-affiliates, as adjusted, as of the date hereof.
Securities Offered
|
Common stock to be offered
by the selling |
1,341,765 shares of common stock, par value $0.01 per share. |
|
Common stock outstanding
prior to this |
8,195,808 shares |
|
Common stock to be
outstanding after |
9,537,573 shares |
|
Use of Proceeds |
We will not receive any proceeds from the sale of shares of our common stock by the selling stockholders. However, we will receive payment in cash upon any exercise of the warrants, and any proceeds we receive will be used for working capital and general corporate purposes. See “Use of Proceeds.” |
|
Risk factors |
This investment involves a high degree of risk. See “Risk Factors” for a discussion of factors you should consider carefully before making an investment decision. |
|
NASDAQ ticker symbol |
FORD |
3
Risk Factors
Investing in our common stock involves a high degree of risk. You should carefully consider the following risk factors and those set forth in our most recent Annual Report on Form 10-K (including our consolidated financial statements and the related notes thereto) on file with the SEC, which are incorporated by reference into this prospectus, as well as the other information in this prospectus or in any accompanying prospectus supplement, before deciding whether to purchase shares of our common stock. Any of these risks, either alone or taken together, as well as other risks and uncertainties not known to us or that we believe to be immaterial, could harm our financial condition, results of operations or cash flows. This prospectus, and any documents that we may incorporate by reference into this prospectus, may contain forward-looking statements that involve risks and uncertainties. Our operating results could differ materially from those anticipated in these forward-looking statements as a result of certain risk factors, including the risks we face as described below and elsewhere in this prospectus. We cannot assure you of a profit or protect you against a loss on the shares of our common stock that you purchase in our Company.
Risks Related to the Offering
Sales of shares issuing in this offering may cause the market price of our shares to decline.
On June 28, 2013, August 7, 2013 and August 14, 2013, the Company completed Private Placements of a total of 648,846 shares of Convertible Preferred Stock and Warrants to purchase 648,846 shares of common stock to the Investors. We have agreed to register with the SEC the shares of common stock underlying the Securities issued in the Private Placements for resale. The registration statement of which this prospectus forms a part has been filed to satisfy this obligation. Upon the effectiveness of the registration statement, an aggregate of 1,341,765 shares of common stock issuable upon the conversion of the Convertible Preferred Stock and issuable upon exercise of the Warrants are expected to be freely tradable in the open market. The sale of a significant amount of these shares of common stock in the open market, or the perception that these sales may occur, could cause the market price of our common stock to decline or become highly volatile.
4
Cautionary Note Regarding Forward-Looking Statements
The SEC encourages companies to disclose forward-looking information so that investors can better understand a company’s future prospects and make informed investment decisions. This prospectus contains such “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may be made directly in this prospectus, and they may also be made a part of this prospectus by reference to other documents filed with the SEC, which is known as “incorporation by reference.”
These “forward-looking statements” are not based on historical fact and involve assessments of certain risks, developments, and uncertainties in our business looking to the future. Such forward looking statements can be identified by the use of forward-looking terminology such as “may,” “will,” “should,” “expect,” “anticipate,” “estimate,” “intend,” “continue,” or “believe,” or the negatives or other variations of these terms or comparable terminology. Forward-looking statements may include projections, forecasts, or estimates of future performance and developments. Forward-looking statements contained in this prospectus are based upon assumptions and assessments that we believe to be reasonable as of the date of this prospectus. Whether those assumptions and assessments will be realized will be determined by future factors, developments, and events, which are difficult to predict and may be beyond our control. Actual results, factors, developments, and events may differ materially from those we assumed and assessed. Risks, uncertainties, contingencies, and developments, including those identified under the heading “Risk Factors” beginning on page 4, could cause our future operating results to differ materially from those set forth in any forward looking statement. There can be no assurance that any such forward looking statement, projection, forecast or estimate contained can be realized or that actual returns, results, or business prospects will not differ materially from those set forth in any forward looking statement.
Given these uncertainties, readers are cautioned not to place undue reliance on such forward-looking statements. The Company disclaims any obligation to update any such factors or to publicly announce the results of any revisions to any of the forward-looking statements contained or incorporated by reference herein to reflect future results, events or developments.
Use of Proceeds
This prospectus relates to shares of our common stock that may be offered and sold from time to time by the selling stockholders. We will not receive any proceeds from the sale of shares of our common stock by the selling stockholders. However, we will receive payment in cash upon any exercise of the warrants, and any proceeds we receive will be used for working capital and general corporate purposes.
The selling stockholders will pay any underwriting discounts and commissions and expenses incurred by the selling stockholders for brokerage, accounting, tax or legal services or any other expenses incurred by the selling stockholders in disposing of the shares. We will bear the costs, fees and expenses incurred to effect the registration of the shares covered by this prospectus, including all registration and filing fees, NASDAQ Capital Market listing fees and fees and expenses of counsel and our independent registered public accounting firm.
5
Market for Common Equity and Related Stockholder Matters
The principal market for our common stock is the NASDAQ Capital Market. Our common stock is traded under the symbol “FORD.” The following table sets forth the high and low sales prices for our common stock on the NASDAQ Capital Market for the periods indicated.
|
|
NASDAQ Capital market |
|
|
|
High |
Low |
|
|
|
|
|
Fiscal 2012 |
|
|
|
1st Quarter |
$ 2.24 |
$ 1.55 |
|
2nd Quarter |
$ 3.24 |
$ 1.65 |
|
3rd Quarter |
$ 2.83 |
$ 1.68 |
|
4th Quarter |
$ 1.83 |
$ 1.02 |
|
Fiscal 2013 |
|
|
|
1st Quarter |
$ 1.50 |
$ 1.08 |
|
2nd Quarter |
$ 2.17 |
$ 1.43 |
|
3rd Quarter |
$ 2.14 |
$ 1.70 |
|
4th Quarter |
$ 1.99 |
$ 1.66 |
|
Fiscal 2014 |
|
|
|
1st Quarter |
$ 1.89 |
$ 1.41 |
|
2nd Quarter |
$ 2.10 |
$ 1.51 |
|
3rd Quarter (through April 2, 2014) |
$ 1.93 |
$ 1.70 |
As of December 5, 2013, there were approximately 110 holders of record of our common stock, excluding approximately 6,939 beneficial holders of common stock whose shares are held in street name. On April 2, 2014, the last reported sale price for our common stock as reported on the NASDAQ SmallCap Market was $1.78 per share.
Dividend Policy
We have not paid any cash dividends on our common stock since 1987 and do not plan to pay cash dividends in the foreseeable future. The payment of dividends in the future, if any, will depend upon our results of operations, as well as our short-term and long-term cash availability, working capital, working capital needs, and other factors, as determined by our Board of Directors. However, on June 28, 2013, August 7, 2013 and August 14, 2013, we completed the Private Placements of the Securities. The first dividend payment with respect to the Convertible Preferred Stock was made on September 30, 2013.
Currently, except as may be provided by applicable laws, there are no contractual or other restrictions on our ability to pay dividends on our common stock if we were to decide to declare and pay them.
Principal Stockholders
Set forth below is information, as of March 17, 2014, with respect to the beneficial ownership of our common stock by (i) each director, (ii) each shareholder who, based on publicly available records, is known by the Company to own beneficially more than five percent (5%) of our common stock and (iii) all our current directors and executive officers, as a group (eight persons). Unless otherwise stated, the address of each person in the table below is c/o Forward Industries, Inc., 477 Rosemary Ave., Suite 219, West Palm Beach, FL 33401.
|
Identity of Beneficial Owner |
Number of Shares
|
Percent of |
|
Directors and Executive Officers: |
|
|
|
Robert Garrett Jr. (b) |
401,157 |
4.7% |
|
James O. McKenna III (c) |
176,953 |
2.1% |
|
Frank LaGrange (Grange) Johnson (d) (e) (f) |
202,855 |
2.4% |
|
Owen P.J. King (d) (f) |
45,000 |
* |
|
John F. Chiste (d) (f) |
45,000 |
* |
|
Timothy Gordon (f) (g) (h) |
113,427 |
1.4% |
|
Howard Morgan (f) (h) |
25,000 |
* |
|
Terence Wise (f) (h) (i) |
1,608,541 |
19.6% |
|
5% or Greater Shareholders: |
|
|
|
Jenny P. Yu (j) |
444,217 |
5.4% |
|
BlackRock, Inc. (k) |
420,476 |
5.1% |
|
|
|
|
|
All directors and executive officers |
2,617,933 |
29.8% |
6
*Less than 1 percent
| (a) |
As of March 17, 2014, there were 8,195,808 shares of common stock outstanding. |
| (b) |
Includes (i) 24,492 shares of restricted common stock previously granted under Forward’s equity plans, (ii) 293,332 shares of common stock subject to options that are currently exercisable or will be exercisable within 60 days of March 17, 2014 and (iii) 83,333 shares of restricted common stock that vest through November 8, 2015. |
| (c) |
Includes (i) 1,425 shares of common stock held by Mr. McKenna’s spouse, as separate property, (ii) 38,028 shares of restricted common stock previously granted under Forward’s equity plans, (iii) 62,000 shares of common stock subject to options exercisable within 60 days of March 17, 2014 and (iv) 70,000 shares of restricted common stock that vest through November 8, 2015. |
| (d) |
Includes 30,000 shares of common stock subject to options exercisable within 60 days of March 17, 2014. |
| (e) |
Includes (i) 81,520 shares of common stock issuable upon the conversion of 76,335 shares of Convertible Preferred Stock owned by Mr. Johnson and (ii) 76,335 shares of common stock issuable upon the exercise of the Warrant held by Mr. Johnson. |
| (f) |
Includes 15,000 shares of restricted common stock that vest over one year beginning on December 8, 2013. |
| (g) |
Includes (i) 40,760 shares of common stock issuable upon the conversion of 38,167 shares of Convertible Preferred Stock owned by Mr. Gordon and (ii) 38,167 shares of common stock issuable upon the exercise of the Warrant held by Mr. Gordon and (iii) 3,000 shares of common stock held in trust for Mr. Gordon’s minor children. |
| (h) |
Includes 10,000 shares of common stock subject to options exercisable within 60 days of March 17, 2014. |
| (i) |
Derived from an amendment to Schedule 13D, filed with the SEC on March 18, 2013. The address of Mr. Wise is Brambledown, 8 Valley Way, Gerrards Cross, Buckinghamshire SL9 7PN, United Kingdom. |
| (j) |
Derived from an amended to Schedule 13D filed with the SEC on May 2, 2013. The address of Ms. Yu is 9255 Doheny Road Apt. 2905, West Hollywood, CA 90069. |
| (k) |
Derived from an amendment to Schedule 13G/A filed with the SEC on September 10, 2013. The address of BlackRock, Inc. is 40 East 52nd Street, New York, NY 10022. |
| (l) |
Includes (i) 475,332 shares of common stock subject to options that are either currently exercisable or that are expected to be exercisable within 60 days of March 17, 2014, (ii) 122,280 shares of common stock issuable upon the conversion of 114,502 shares of Convertible Preferred Stock and (iii) 114,502 shares of common stock issuable upon the conversion of Warrants. |
7
The Selling Stockholders
This prospectus covers an aggregate of 1,341,765 shares of our common stock, consisting of (i) 692,919 shares issuable upon the conversion of the Convertible Preferred Stock and (ii) 648,846 shares issuable upon the exercise of the Warrants. The foregoing outstanding shares of Convertible Preferred Stock and Warrants were issued under securities purchase agreements in the Private Placements.
We are registering the shares of common stock in accordance with the terms of the registration rights agreements we entered into with the selling stockholders as part of the Private Placements in order to permit the selling stockholders to offer the shares of common stock for resale from time to time. The selling stockholders may from time to time offer and sell pursuant to this prospectus any or all of the below listed shares of common stock owned by them. The registration of these shares does not require that any of the shares be offered or sold by the selling stockholders. The selling stockholders may from time to time offer and sell all or a portion of their shares in the over-the-counter market, in negotiated transactions, or otherwise, at prices then prevailing or related to the then current market price or at negotiated prices.
The registered shares may be sold directly or through brokers or dealers, or in a distribution by one or more underwriters on a firm commitment or best efforts basis. To the extent required, the names of any agent or broker-dealer and applicable commissions or discounts and any other required information with respect to any particular offer will be set forth in a prospectus supplement. Please see “Plan of Distribution.” The selling stockholders and any agents or broker-dealers that participate with the selling stockholders in the distribution of registered shares may be deemed to be “underwriters” within the meaning of the Securities Act, and any commissions received by them and any profit on the resale of the registered shares may be deemed to be underwriting commissions or discounts under the Securities Act.
The following table sets forth:
the names of the selling stockholders;
the number of shares of common stock beneficially owned by each selling stockholder that may be offered for the account of such selling stockholder under this prospectus; and
the number of shares of common stock beneficially owned by each selling stockholder upon completion of this offering. Because the selling stockholders are not required to sell any of the shares being registered under this prospectus, the following table assumes the selling stockholders will sell all of the shares listed in this prospectus.
Such information was obtained from the selling stockholders. Unless otherwise stated, none of the selling stockholders or any of their respective affiliates has held a position or office, or had any other material relationship, with us. The term “selling stockholder” includes each entity listed below and its transferees, pledgees, donees or other successors.
|
|
Shares Beneficially Owned Before Offering |
|
Shares Beneficially Owned After Offering |
|||
|
Selling Stockholder |
Number |
Percent |
Shares to be Sold |
Number |
Percent |
|
|
Grange Johnson (a) |
202,855 |
2.4% |
157,855 |
45,000 |
* |
|
|
Timothy Gordon (b) |
113,427 |
1.4% |
78,927 |
34,500 |
* |
|
|
Cibelli Management, LLC |
26,308 |
* |
26,308 |
0 |
* |
|
|
Groservice Acquisition Corp. |
157,855 |
1.9% |
157,855 |
0 |
* |
|
|
Robert A. Guida |
105,237 |
1.3% |
105,237 |
0 |
* |
|
|
Mario Rodriguez |
105,237 |
1.3% |
105,237 |
0 |
* |
|
|
Jaime Lester |
157,855 |
1.9% |
157,855 |
0 |
* |
|
|
Allan S. Gordon (c) |
78,926 |
1.0% |
78,926 |
0 |
* |
|
|
Julie Richardson |
105,237 |
1.3% |
105,237 |
0 |
* |
|
|
Michael Spain |
105,237 |
1.3% |
105,237 |
0 |
* |
|
|
Joseph E. Reece |
157,855 |
1.9% |
157,855 |
0 |
* |
|
|
Robert Neal |
105,237 |
1.3% |
105,237 |
0 |
* |
|
___________
*Less than 1 percent
8
| (a) |
Includes (i) 30,000 shares of common stock subject to options exercisable within 60 days of March 17, 2014, (ii) 81,520 shares of common stock issuable upon the conversion of 76,335 shares of Convertible Preferred Stock owned by Mr. Johnson, (iii) 76,335 shares of common stock issuable upon the exercise of the Warrant held by Mr. Johnson. Mr. Johnson has been Chairman of our Board of Directors since August 2010 and (iv) 15,000 shares of restricted stock that vest over one year beginning December 8, 2013. |
| (b) |
Includes (i) 40,760 shares of common stock issuable upon the conversion of 38,167 shares of Convertible Preferred Stock owned by Mr. Gordon, (ii) 38,167 shares of common stock issuable upon the exercise of the Warrant held by Mr. Gordon, (iii) 3,000 shares of common stock held in trust for Mr. Gordon’s minor children, (iv) 10,000 shares of common stock subject to options exercisable within 60 days of March 17, 2014 and (v) 15,000 shares of restricted stock that vest over one year beginning December 8, 2013. Mr. Gordon has been a member of the Board of Directors since April 2012. Mr. Gordon disclaims beneficial ownership of all securities of the Company owned by Allan S. Gordon, his father. |
| (c) |
Allan S. Gordon is the father of Timothy Gordon, a member of our Board of Directors. Allan S. Gordon disclaims beneficial ownership of all securities of the Company owned by Timothy Gordon. |
9
DESCRIPTION OF THE PRIVATE PLACEMENTS
General
On June 28, 2013, the Company completed the sale of (i) 381,674 shares of its newly authorized Convertible Preferred Stock and (ii) Warrants to purchase a total of 381,674 shares of the Company’s common stock to accredited investors in a private placement pursuant to the terms of securities purchase agreements, dated June 28, 2013, by and between the Company and each Investor. The June 28, 2013 private placement included purchases of Securities by Grange Johnson and Timothy Gordon, directors of the Company, who, in the aggregate, purchased 114,502 shares of Convertible Preferred Stock and Warrants.
On August 7, 2013, the Company completed the sale of (i) an additional 216,282 shares of its Convertible Preferred Stock and (ii) Warrants to purchase a total of 216,282 shares of the Company’s Common Stock to accredited investors in a private placement pursuant to the terms of a securities purchase agreement, dated August 7, 2013, by and between the Company and such accredited investors.
On August 14, 2013, the Company completed the sale of (i) an additional 50,890 shares of its Convertible Preferred Stock and (ii) Warrants to purchase a total of 50,890 shares of the Company’s Common Stock to accredited investors in a private placement pursuant to the terms of a securities purchase agreement, dated August 14, 2013, by and between the Company and such accredited investors.
The total aggregate purchase price paid by accredited investors via the June 28, 2013, August 7, 2013 and August 14, 2013 private placements for each share of Convertible Preferred Stock and Warrant was $1.965. The June 28, 2013, August 7, 2013 and August 14, 2013 Private Placements resulted in gross proceeds of approximately $1,275,000 to the Company. The Company has sold a total of 648,846 shares of Convertible Preferred Stock and Warrants to purchase 648,846 shares of Common Stock through these Private Placements. The Company may sell additional shares of Convertible Preferred Stock, together with related Warrants, in one or more subsequent transactions.
The total purchase price paid by the Investors for each share of Convertible Preferred Stock and Warrant purchased in the closings was $1.965, consisting of (i) fair values ranging from $1.105 to $1.145 in respect of the Convertible Preferred Stock, plus (ii) fair values ranging from $0.82 to $0.86 in respect of the Warrant. The Warrants have an initial exercise price of $1.84 per share, subject to adjustment upon the occurrence of certain customary events. The Warrants are exercisable at any time on or after January 1, 2014 and terminate on the 10-year anniversary of the Initial Exercise Date. Each share of Convertible Preferred Stock is convertible into one share of common stock at an initial conversion price of $1.84 per share, subject to adjustment upon the occurrence of certain customary events. At the initial Conversion Price, the total of 648,846 shares of Convertible Preferred Stock issued in the Private Placement as of the date of the Closing are convertible into an aggregate of 692,919 shares of our common stock. The proceeds from these Private Placements of $1,275,000 have been allocated to the Convertible Preferred Stock and the Warrants based upon their fair values assigned (net of issuance costs of approximately $69,000) of approximately $693,000 and $513,000, respectively, as of the dates of issuance.
As of December 31, 2013 and September 30, 2013, the carrying value of the Convertible Preferred Stock was approximately $746,000 and $717,000, respectively, and is included on the Company’s consolidated balance sheets as temporary equity. The change in the carrying value, or accretion, of the Convertible Preferred Stock from the issuance dates to December 31, 2013 is classified as a preferred stock dividend in the amount of approximately $24,000 and is included as a component of “Net income applicable to common equity” in calculating income per share, which was approximately $30,000 for the three month period ended December 31, 2013. As a result of the Convertible Preferred Stock containing a beneficial conversion feature, whereby the accounting conversion price is lower than the fair value of our common stock, the Company recorded a preferred stock dividend in the amount of approximately $508,000 for the fiscal year ended September 30, 2013. This amount has also been recorded as an increase to additional paid in capital.
Dividends on the Convertible Preferred Stock are payable, on a cumulative basis, in cash, at the rate per annum of 6% of the Liquidation Preference (as defined below) and are payable quarterly, in arrears, on each March 31, June 30, September 30 and December 31, commencing on September 30, 2013. The Company is prohibited from paying any dividend with respect to shares of our common stock or other junior securities in any quarter unless full dividends are paid on the Convertible Preferred Stock in such quarter. Dividends on the Convertible Preferred Stock totaled approximately $19,000 for the three months ended December 31, 2013. These dividends, in addition to the accretion, totaled $49,000 for the three months ended December 31, 2013.
10
In the event of a liquidation (or deemed liquidation, as described below) of the Company, the holders of the Convertible Preferred Stock will receive in preference to the holders of Common Stock and any junior securities of the Company an amount (the “Liquidation Preference”) equal to (i) $1.965 (the “Original Issue Price”) per each outstanding share of Convertible Preferred Stock (subject to adjustment upon the occurrence of certain customary events), plus (ii) any accrued but unpaid dividends. A Change of Control of the Company (as defined in the Certificate of Amendment of our Certificate of Incorporation) will be treated as a liquidation at the option of the holders of a majority of the Convertible Preferred Stock; provided that the amount paid to holders of Convertible Preferred Stock in such event will be equal to 101% of the Original Issue Price, plus accrued but unpaid dividends.
Each share of Convertible Preferred Stock is convertible at any time, at the option of the holder, into shares of our common stock at the then applicable Conversion Price. In addition, upon the consent of 80% of the holders of the Convertible Preferred Stock, the Convertible Preferred Stock automatically will be converted to shares of our common stock at the then-applicable Conversion Price.
On or after June 28, 2018, the Company may, at its option and upon at least 30 days prior written notice to the holders of the Convertible Preferred Stock, redeem all or any portion of the outstanding Convertible Preferred Stock in cash at a redemption price equal to the full Liquidation Preference as of the redemption date. In addition, at any time on or after June 28, 2023, each holder of the Convertible Preferred Stock will have the right to require the Company to redeem (provided that funds are legally available to do so) all or any portion of such holder’s outstanding Convertible Preferred Stock at a redemption price equal to the full Liquidation Preference of such shares of Convertible Preferred Stock as of the redemption date.
The Convertible Preferred Stock will vote together with our common stock on an as-converted basis on all matters except as required by law. In addition, for so long as 50% of the shares of Convertible Preferred Stock remains outstanding, without the approval of the holders of a majority of the Convertible Preferred Stock, voting as a separate class, the Company may not: (i) authorize or issue any equity security senior to the Convertible Preferred Stock; (ii) declare or pay any dividends on our common stock or any series of preferred stock that ranks junior to the Convertible Preferred Stock; (iii) increase or decrease the total number of authorized shares of Convertible Preferred Stock; (iv) alter or change the rights, preferences or privileges of the Convertible Preferred Stock so as to affect materially and adversely the Convertible Preferred Stock; or (v) increase the authorized capitalization of the Company, or otherwise amend its certificate of incorporation or bylaws in a manner which adversely affects the rights or preferences of the Convertible Preferred Stock.
As of December 31, 2013 and September 30, 2013, the liability associated with the Warrants was approximately $412,000 and $464,000 (net of issuance costs) and is included in the “Accrued expenses and other current liabilities” line of the Company’s consolidated balance sheets.
The fair value of the Warrants was determined using a Black-Scholes closed-form call option pricing model, which is considered a level 3 instrument under the fair value hierarchy. The fair value of the Warrants were estimated using the following assumptions as of December 31, 2013 and September 30, 2013:
|
December 31, 2013 |
September 30, 2013 |
|
|
Risk-free interest rate |
3.0% |
2.6% |
|
Dividend yield |
-- |
-- |
|
Volatility |
32.9% |
30.0% |
|
Expected term (in years) |
10.0 |
10.3 |
11
The change in the fair value of the convertible preferred stock warrant liability for the three months ended December 31, 2013 is summarized below:
|
Balance at September 30, 2013 |
$493,123 |
|
Decrease in fair value |
(51,908) |
|
Closing balance |
$441,215 |
The following table presents the Company’s fair value hierarchy for liabilities, consisting of a warrant liability, measured at fair value and prior to issuance costs, on a recurring basis at December 31, 2013 and September 30, 2013:
|
Level 1 |
Level 2 |
Level 3 |
Total |
|
|
Warrant liability at December 31, 2013 |
$ — |
$ — |
$441,215 |
$441,215 |
|
Warrant liability at September 30, 2013 |
$ — |
$ — |
$493,123 |
$493,123 |
12
Plan of Distribution
The common stock offered by this prospectus is being offered by the selling stockholders. The common stock may be sold or distributed from time to time by the selling stockholders directly to one or more purchasers or through brokers, dealers, or underwriters who may act solely as agents at market prices prevailing at the time of sale, at prices related to the prevailing market prices, at negotiated prices, or at fixed prices, which may be changed. The sale of the common stock offered by this prospectus may be effected in one or more of the following methods:
-
ordinary brokers’ transactions;
-
transactions involving cross or block trades;
-
through brokers, dealers, or underwriters who may act solely as agents;
-
“at the market” into an existing market for the common stock;
-
in other ways not involving market makers or established business markets, including direct sales to purchasers or sales effected through agents;
-
in privately negotiated transactions; or
-
any combination of the foregoing.
The selling stockholders may, from time to time, pledge or grant a security interest in some or all of the shares of common stock owned by them and, if they default in the performance of their secured obligations, the pledgees or secured parties may offer and sell the shares of common stock, from time to time, under this prospectus, or under an amendment to this prospectus under Rule 424(b)(3) or other applicable provision of the Securities Act, amending the list of selling stockholders to include the pledgee, transferee or other successors in interest as selling stockholders under this prospectus. The selling stockholders also may transfer the shares of common stock in other circumstances, in which case the transferees, pledgees or other successors in interest will be the selling beneficial owners for purposes of this prospectus.
In connection with the sale of our common stock or interests therein, the selling stockholders may enter into hedging transactions with broker-dealers or other financial institutions, which may in turn engage in short sales of the common stock in the course of hedging the positions they assume. The selling stockholders may also sell shares of our common stock short and deliver these securities to close out their short positions, or loan or pledge the common stock to broker-dealers that in turn may sell these securities. The selling stockholders may also enter into option or other transactions with broker-dealers or other financial institutions or the creation of one or more derivative securities which require the delivery to such broker-dealer or other financial institution of shares offered by this prospectus, which shares such broker-dealer or other financial institution may resell pursuant to this prospectus (as supplemented or amended to reflect such transaction).
The aggregate proceeds to the selling stockholders from the sale of the common stock offered by them will be the purchase price of the common stock less discounts or commissions, if any. Each of the selling stockholders reserves the right to accept and, together with their agents from time to time, to reject, in whole or in part, any proposed purchase of common stock to be made directly or through agents. We will not receive any of the proceeds from this offering. However, we will receive payment in cash upon any exercise of the warrants, and any proceeds we receive will be used for general corporate purposes, including working capital and in connection with potential acquisition targets that would be complementary to our existing business and allow us to further leverage our operating infrastructure, if any are identified and acquired.
The selling stockholders also may resell all or a portion of the shares in open market transactions in reliance upon Rule 144 under the Securities Act, provided that they meet the criteria and conform to the requirements of that rule.
13
The selling stockholders and any underwriters, broker-dealers or agents that participate in the sale of the common stock or interests therein may be “underwriters” within the meaning of Section 2(11) of the Securities Act. Any discounts, commissions, concessions or profit they earn on any resale of the shares may be underwriting discounts and commissions under the Securities Act. Selling stockholders who are “underwriters” within the meaning of Section 2(11) of the Securities Act will be subject to the prospectus delivery requirements of the Securities Act.
To the extent required, the shares of our common stock to be sold, the names of the selling stockholders, the respective purchase prices and public offering prices, the names of any agents, dealers or underwriters and any applicable commissions or discounts with respect to a particular offer will be set forth in an accompanying prospectus supplement or, if appropriate, a post-effective amendment to the registration statement that includes this prospectus.
In order to comply with the securities laws of certain states, if applicable, the shares of common stock may be sold in these jurisdictions only through registered or licensed brokers or dealers. In addition, in certain states the shares of common stock may not be sold unless they have been registered or qualified for sale or an exemption from the registration or qualification requirements is available and complied with.
We have advised the selling stockholders that the anti-manipulation rules of Regulation M under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), may apply to sales of shares in the market and to the activities of the selling stockholders and their affiliates. In addition, to the extent applicable we will make copies of this prospectus (as it may be supplemented or amended from time to time) available to the selling stockholders for the purpose of satisfying the prospectus delivery requirements of the Securities Act. The selling stockholders may indemnify any broker-dealer that participates in transactions involving the sale of the shares against certain liabilities, including liabilities arising under the Securities Act.
We have agreed to indemnify the selling stockholders against certain liabilities, including liabilities under the Securities Act, the Exchange Act and other federal or state securities laws, relating to the registration of the shares offered by this prospectus.
We have agreed with the selling stockholders to keep the registration statement of which this prospectus constitutes a part effective until the earlier of (i) such time as all of the shares of common stock covered by the registration statement have been sold publicly or (ii) such time as all of the shares of common stock covered by the registration statement may be sold by the selling stockholders during a three-month period without registration pursuant to Rule 144 or another similar exemption under the Securities Act.
14
Description of Capital Stock
The following description of our capital stock is a summary and is subject to and qualified in its entirety by the provisions of our Amended and Restated Certificate of Incorporation, as amended (the “Certificate of Incorporation”), our Third Amended and Restated By-Laws, as amended (the “By-Laws”), and the relevant provisions of the law of the State of New York.
General
We are authorized to issue up to 44,000,000 shares of capital stock, $0.01 par value, of which 40,000,000 may be common stock and 4,000,000 may be preferred stock.
Common Stock
As of March 17, 2014, there were 8,195,808 shares of our common stock issued and outstanding, held of record by approximately 110 holders of record. The holders of common stock are entitled to ratably receive dividends, if any, as and when declared from time to time by our Board of Directors out of funds legally available therefor, subject to the dividend provisions applicable to holders of our preferred stock as described below. Upon liquidation, dissolution or winding up of our affairs, the holders of common stock will be entitled to participate ratably in our net assets available for distribution to holders of common stock, subject to the liquidation provisions applicable to holders of our preferred stock as described below. Our common stock is not redeemable, has no subscription or conversion rights and does not entitle the holder to any preemptive rights. In addition, the holders of our common stock are not subject to any calls or assessments.
Each holder of our common stock is entitled to one vote for each share of our common stock owned. Holders of our common stock do not have cumulative voting rights. Shares of our common stock are traded on the Nasdaq Capital Market under the symbol “FORD.”
Our Certificate of Incorporation provides that the number of directors shall be not less than three and not more than seven.
Our By-Laws provide that special meetings of the shareholders may be called at any time by (i) our President, (ii) the Chairman of our Board of Directors, (iii) our Board of Directors pursuant to a resolution adopted by a majority of our entire Board of Directors, or (iv) qualified shareholders holding at least thirty percent (30%) of all the votes entitled to be cast on any issue proposed to be considered at the special meeting. A qualified shareholder is a person who has been a shareholder of Forward for at least six months immediately preceding the request for a special meeting.
Preferred Stock
We may issue from time to time up to 4,000,000 shares of preferred stock in one or more series, and in connection with the creation of each such series, fix the number of shares of such series, and the designations, relative rights, preferences, and limitations of such series.
Series A Participating Preferred Stock
On April 26, 2013, in connection with our Board of Directors adopting a shareholder rights plan, we created a new class of preferred stock designated as Series A Participating Preferred Stock (the “Series A Preferred”), of which none is issued and outstanding. On the same day, our Board of Directors declared a dividend distribution of one right (a “Right”) for each outstanding share of our common stock to shareholders of record at the close of business on May 6, 2013, and for each share of common stock issued (including shares distributed from the treasury) by the Company thereafter and prior to the Distribution Date (as defined below). Each Right entitled the registered holder, subject to the terms of the rights agreement entered into on April 26, 2013 between the Company and American Stock Transfer & Trust Company, LLC, as rights agent (the “Rights Agreement”), to purchase from the Company one one-thousandth of a share of Series A Preferred, $0.01 par value per share, at an exercise price of $4.00 per one one-thousandth of a share of Series A Preferred, subject to adjustment. Subject to certain exceptions specified in the Rights Agreement, the Rights will separate from the common stock and become exercisable on the distribution date (the “Distribution Date”), which will occur on the earlier of (i) the 10th business day (or such later date as may be determined by the Board of Directors) after the public announcement that an acquiring person (as further described in the Rights Agreement) has acquired beneficial ownership of 20% or more of the common stock then outstanding or (ii) the 10th business day (or such later date as may be determined by the Board of Directors) after a person or group announces a tender or exchange offer that would result in a person or group of affiliated and associated persons beneficially owning 20% or more of the common stock then outstanding.
15
The holders of Series A Preferred are also entitled to quarterly dividends, as and when declared by our Board of Directors, payable in cash on the last day of March, June, September and December (each, a “Quarterly Dividend Payment Date”) in each year in an amount per share equal to the greater of $1.00 and 1,000 times the aggregate per share amount of all cash dividends, and 1,000 times the aggregate per share amount of all non-cash dividends or other distributions other than a dividend payable in shares of common stock or a subdivision thereof, declared on our common stock since the immediately preceding Quarterly Dividend Payment Date. The Company must declare a dividend or distribution on the Series A Preferred immediately after it declares a dividend or distribution on the common stock (other than a dividend payable in shares of common stock), except that in the event no dividend or distribution is declared on the common stock between any Quarterly Dividend Payment Date and the next, a dividend of $1.00 per share on the Series A Preferred must nevertheless be paid on the next Quarterly Dividend Payment Date.
Upon liquidation, dissolution or winding up of our affairs, no distribution will be made to holders of shares of capital stock ranking junior to the Series A Preferred unless, prior thereto, the holders of shares of Series A Preferred will have received an amount equal to $1,000 per share of Series A Preferred, plus an amount equal to accrued and unpaid dividends and distributions thereon, whether or not declared, to the date of such payment (the “Series A Liquidation Preference”). Following such payment, no additional distributions will be made to holders of shares of Series A Preferred unless, prior thereto, the holders of shares of our common stock will have received an amount per share equal to the quotient obtained by dividing (i) the Series A Liquidation Preference by (ii) 1,000 (as appropriately adjusted to reflect events as stock splits, stock dividends and recapitalizations with respect to our common stock) (such number in clause (ii), the “Adjustment Number”). Following the payments referred to in the immediately preceding two sentences, holders of Series A Preferred and holders of shares of our common stock will receive their ratable and proportionate share of the remaining assets to be distributed in the ratio of the Adjustment Number to one with respect to such preferred stock and common stock, on a per share basis, respectively.
Each share of Series A Preferred entitles the holder thereof to 1,000 votes on all matters submitted to a vote of the shareholders of the Company. In the event dividends on any Series A Preferred is in arrears in an amount equal to six quarterly dividends thereon, then during such period until all accrued and unpaid dividends have been declared and paid for or set apart for payment, all holders of preferred stock (including Series A Preferred) with dividends in arrears in an amount equal to six quarterly dividends thereon will have the right (voting as a single class irrespective of series) to elect two directors to our Board of Directors.
6% Senior Convertible Preferred Stock
On June 28, 2013, we created a new class of preferred stock designated as 6% Senior Convertible Preferred Stock, or the Convertible Preferred Stock, of which 648,846 shares are issued and outstanding.
Dividends on the Convertible Preferred Stock are payable, on a cumulative basis, in cash, at the rate per annum of 6% of the Liquidation Preference and are payable quarterly, in arrears, on each March 31, June 30, September 30 and December 31, commencing on September 30, 2013. The Company is prohibited from paying any dividend with respect to shares of our common stock or other junior securities (including the Series A Preferred) in any quarter unless full dividends are paid on the Convertible Preferred Stock in such quarter.
In the event of a liquidation or deemed liquidation of the Company, the holders of the Convertible Preferred Stock will receive in preference to the holders of Common Stock and any junior securities of the Company the Liquidation Preference. A Change of Control of the Company will be treated as a liquidation at the option of the holders of a majority of the Convertible Preferred Stock; provided that the amount paid to holders of Convertible Preferred Stock in such event will be equal to 101% of the Original Issue Price, plus accrued but unpaid dividends.
16
The Convertible Preferred Stock will vote together with our common stock on an as-converted basis on all matters except as required by law. In addition, for so long as 50% of the shares of Convertible Preferred Stock remains outstanding, without the approval of the holders of a majority of the Convertible Preferred Stock, voting as a separate class, the Company may not: (i) authorize or issue any equity security senior to the Convertible Preferred Stock; (ii) declare or pay any dividends on our common stock or any series of preferred stock that ranks junior to the Convertible Preferred Stock; (iii) increase or decrease the total number of authorized shares of Convertible Preferred Stock; (iv) alter or change the rights, preferences or privileges of the Convertible Preferred Stock so as to affect materially and adversely the Convertible Preferred Stock; or (v) increase the authorized capitalization of the Company, or otherwise amend its certificate of incorporation or bylaws in a manner which adversely affects the rights or preferences of the Convertible Preferred Stock.
Anti-Takeover Provisions
As of March 17, 2014, there are 648,846 shares of preferred stock issued and outstanding, of which all were shares of Convertible Preferred Stock and none of Series A Preferred. Our ability to issue the authorized but unissued shares of preferred stock, including the Series A Preferred, could be used to impede takeovers of our company. Under certain circumstances, the issuance of the preferred stock could make it more difficult for a third party to gain control of Forward, adversely affect the voting power or other rights of the holders of our common stock, discourage bids for the common stock at a premium, or otherwise adversely affect the market price of our common stock.
In addition, as described above, on April 26, 2013, our Board of Directors adopted a shareholder rights plan pursuant to the Rights Agreement in order to encourage anyone seeking to acquire us to negotiate with our Board of Directors prior to attempting a takeover. While the plan is designed to guard against coercive or unfair tactics to gain control of us, the plan may have the effect of making more difficult or delaying any attempts by others to obtain control of us.
17
Legal Matters
The validity of the securities offered by this prospectus will be passed upon for us by Olshan Frome Wolosky LLP, New York, New York.
Experts
The consolidated financial statements of Forward Industries, Inc. and Subsidiaries as of September 30, 2013 and 2012 have been incorporated by reference into this prospectus and in the registration statement in reliance upon the report of CohnReznick LLP, independent registered public accounting firm, and upon the authority of said firm as experts in auditing and accounting.
Where You Can Find More Information
This prospectus is part of a registration statement on Form S-1 that we filed with the SEC. Certain information in the registration statement has been omitted from this prospectus in accordance with the rules of the SEC. Statements contained in this prospectus as to the contents of any contract, agreement or other document are summaries of the material terms of that contract, agreement or other document. With respect to each of these contracts, agreements or other documents filed or incorporated by reference as an exhibit to the registration statement, reference is made to the exhibits for a more complete description of the matter involved.
We are a reporting company and file annual, quarterly and current reports, proxy statements and other information with the SEC. You may read and copy any document we file with the SEC at the SEC’s Public Reference Room at 100 F Street, N.E., Washington, D.C. 20549. Please call the SEC at 1-800-SEC-0330 for more information about the operation of the Public Reference Room. Our SEC filings are also available at the SEC’s website at www.sec.gov. We maintain a website at www.forwardindustries.com. Information contained in or accessible through our website is not and should not be considered a part of this prospectus and you should not rely on that information in deciding whether to invest in our common stock, unless that information is also in or incorporated by reference in this prospectus.
18
Incorporation of Certain Information By Reference
The SEC allows us to “incorporate by reference” information we file with it into our registration statement on Form S-1 of which this prospectus is a part, which means that we can disclose important information to you by referring you to other documents. The information incorporated by reference is an important part of this prospectus.
We incorporate by reference the documents listed below:
our Annual Report on Form 10-K for the fiscal year ended September 30, 2013, filed on January 14, 2014;
our Quarterly Report on Form 10-Q for the quarter ended December 31, 2013, filed on February 13, 2014; and
our Current Reports on Form 8-K filed with the SEC on October 15, 2013, December 11, 2013, December 17, 2013, January 17, 2014, February 18, 2014 and March 19, 2014 (other than portions of those documents designated as “furnished”).
You may request a copy of these filings incorporated by reference in this prospectus, other than an exhibit to these filings unless we have specifically incorporated that exhibit by reference into the filing, at no cost, by writing or telephoning us at the following address and telephone number:
Forward Industries, Inc.
477 Rosemary Ave., Suite 219
West Palm Beach, FL 33401
(561) 465-0030
Any statement contained in a document incorporated or deemed to be incorporated by reference in this prospectus will be deemed modified, superseded or replaced for purposes of this prospectus to the extent that a statement contained in this prospectus or in any subsequently filed document that also is or is deemed to be incorporated by reference in this prospectus modifies, supersedes or replaces such statement.
19
1,341,765 Shares of Common Stock
Forward Industries, Inc.
|
|
PROSPECTUS |
|
April 4, 2014